Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 16:14:1213386.
doi: 10.3389/fimmu.2023.1213386. eCollection 2023.

Editorial: Nanobody-based cancer immunotherapy and immunoimaging

Mahdie Jafari  1 , Amirhosein Maali  1 , Mohammad Ali Shokrgozar  2 , Zahra Sharifzadeh  1
Affiliations
Editorial

Editorial: Nanobody-based cancer immunotherapy and immunoimaging

Mahdie Jafari et al. Front Immunol. .
No abstract available

Keywords: cancer; immunoimaging; immunotherapy; nanobodies; single domain antibodies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Nanobody-based cancer immunotherapy and immunoimaging

References

    1. Kijanka M, Dorresteijn B, Oliveira S, van Bergen en Henegouwen PM. Nanobody-based cancer therapy of solid tumors. Nanomed (London England) (2015) 10(1):161–74. doi: 10.2217/nnm.14.178 - DOI - PubMed
    1. Lecocq Q, De Vlaeminck Y, Hanssens H, D’Huyvetter M, Raes G, Goyvaerts C, et al. . Theranostics in immuno-oncology using nanobody derivatives. Theranostics (2019) 9(25):7772–91. doi: 10.7150/thno.34941 - DOI - PMC - PubMed
    1. Verhaar ER, Woodham AW, Ploegh HL. Nanobodies in cancer. Semin Immunol (2021) 52:101425. doi: 10.1016/j.smim.2020.101425 - DOI - PMC - PubMed

Publication types

Substances